These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36052559)
1. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer Zhao Y; Yao H; Yang K; Han S; Chen S; Li Y; Chen S; Huang K; Lian G; Li J Biomater Sci; 2022 Oct; 10(20):5989-6002. PubMed ID: 36052559 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis. Tian Z; Tan Y; Lin X; Su M; Pan L; Lin L; Ou G; Chen Y Transl Res; 2023 May; 255():66-76. PubMed ID: 36400307 [TBL] [Abstract][Full Text] [Related]
3. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372 [TBL] [Abstract][Full Text] [Related]
4. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
5. COMP promotes pancreatic fibrosis by activating pancreatic stellate cells through CD36-ERK/AKT signaling pathways. Wang Y; Li HT; Liu G; Jiang CS; Ni YH; Zeng JH; Lin X; Wang QY; Li DZ; Wang W; Zeng XP Cell Signal; 2024 Jun; 118():111135. PubMed ID: 38479555 [TBL] [Abstract][Full Text] [Related]
6. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952 [TBL] [Abstract][Full Text] [Related]
7. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy. Han H; Hou Y; Chen X; Zhang P; Kang M; Jin Q; Ji J; Gao M J Am Chem Soc; 2020 Mar; 142(10):4944-4954. PubMed ID: 32069041 [TBL] [Abstract][Full Text] [Related]
8. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway. Tang D; Wu Q; Zhang J; Zhang H; Yuan Z; Xu J; Chong Y; Huang Y; Xiong Q; Wang S; Tian Y; Lu Y; Ge X; Shen W; Wang D Oncol Rep; 2018 Mar; 39(3):1347-1355. PubMed ID: 29328490 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602 [TBL] [Abstract][Full Text] [Related]
10. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719 [No Abstract] [Full Text] [Related]
11. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway. Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669 [TBL] [Abstract][Full Text] [Related]
12. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296 [TBL] [Abstract][Full Text] [Related]
13. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling. Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868 [TBL] [Abstract][Full Text] [Related]
14. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters. Qiu F; Chen J; Cao J; Diao F; Huang P Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228 [TBL] [Abstract][Full Text] [Related]
15. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422 [TBL] [Abstract][Full Text] [Related]
16. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203 [TBL] [Abstract][Full Text] [Related]
17. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy. Song J; Xu J; Guo J; Shang Y; Wang J; Wang T Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437 [TBL] [Abstract][Full Text] [Related]
18. Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells. Shabana AM; Kambhampati SP; Hsia RC; Kannan RM; Kokkoli E Int J Pharm; 2021 Jan; 593():120139. PubMed ID: 33278494 [TBL] [Abstract][Full Text] [Related]
19. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Yang Y; Cheng T; Xie P; Wang L; Chen H; Cheng Z; Zhou J Drug Dev Res; 2022 Feb; 83(1):64-74. PubMed ID: 34189738 [TBL] [Abstract][Full Text] [Related]
20. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]